Home GenVec

GenVec

acquired
IPO
Vaccine Developer

Basic Information

GenVec is a biopharmaceutical company that uses differentiated proprietary technology to create superior therapies and vaccines. GenVec is collaborating with major companies and organizations such as Novartis, Merial, and the U.S. government to support a range of product programs addressing the prevention and treatment of significant human and animal health issues. GenVec’s development programs target therapeutic areas including hearing loss and balance disorders, as well as vaccines for the prevention of infectious diseases such as respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, influenza, malaria, and human immunodeficiency virus (HIV). In the field of animal health, GenVec is developing a vaccine for foot-and-mouth disease.
GenVec, Inc.
Maryland,United States of America
15~50 people
January 01, 1992
cbyroad@genvec.com